Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 3 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of FBXL22 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 92% | 1122.56 | 226 / 245 | 97% | 3.76 | 488 / 502 |
ovary | 51% | 249.55 | 92 / 180 | 81% | 1.95 | 347 / 430 |
bladder | 95% | 1541.86 | 20 / 21 | 36% | 0.94 | 182 / 504 |
uterus | 96% | 2568.42 | 164 / 170 | 33% | 3.08 | 151 / 459 |
esophagus | 78% | 1017.96 | 1132 / 1445 | 38% | 0.67 | 69 / 183 |
intestine | 80% | 1944.34 | 768 / 966 | 34% | 0.68 | 181 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.89 | 1 / 1 |
blood vessel | 98% | 1550.91 | 1311 / 1335 | 0% | 0 | 0 / 0 |
stomach | 51% | 564.03 | 183 / 359 | 47% | 1.46 | 134 / 286 |
thymus | 22% | 46.90 | 144 / 653 | 70% | 1.77 | 422 / 605 |
brain | 22% | 50.16 | 589 / 2642 | 67% | 1.26 | 472 / 705 |
breast | 29% | 77.69 | 133 / 459 | 60% | 1.14 | 668 / 1118 |
heart | 85% | 596.54 | 733 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.48 | 1 / 328 | 46% | 0.96 | 81 / 178 |
lung | 11% | 26.04 | 66 / 578 | 26% | 0.71 | 301 / 1155 |
adipose | 26% | 115.38 | 318 / 1204 | 0% | 0 | 0 / 0 |
skin | 8% | 21.06 | 151 / 1809 | 16% | 0.25 | 75 / 472 |
kidney | 7% | 14.33 | 6 / 89 | 16% | 0.25 | 140 / 901 |
muscle | 15% | 35.47 | 119 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 0.15 | 10 / 80 |
adrenal gland | 1% | 3.54 | 3 / 258 | 8% | 0.12 | 18 / 230 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.10 | 3 / 45 |
liver | 0% | 0 | 0 / 226 | 3% | 0.04 | 13 / 406 |
spleen | 3% | 6.17 | 7 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005730 | Cellular component | nucleolus |
GO_0005829 | Cellular component | cytosol |
GO_0030018 | Cellular component | Z disc |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXL22 |
Protein name | F-box and leucine rich repeat protein 22 F-box and leucine-rich protein 22 |
Synonyms | |
Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Promotes ubiquitination of sarcomeric proteins alpha-actinin-2 (ACTN2) and filamin-C (FLNC). . |
Accessions | ENST00000638704.2 ENST00000360587.2 H0YMQ4 ENST00000560325.1 ENST00000534939.2 R4GNI3 A0A1W2PQW8 Q6P050 |